Anthropic IPO: Chase the Allocation or Wait for the First Trading Day?

$Anthropic(ANT)$  IPO is attracting extraordinary attention, with reported demand reaching approximately six times the number of shares available.

The company behind Claude AI is preparing for its Nasdaq debut under the ticker ANT, with an indicative price range of $70–$78 per share.

According to its November 10 prospectus, Anthropic plans to offer 825 million shares, potentially raising approximately $64.35 billion at the top of the range.

Bloomberg has reported that existing investors are receiving priority in the allocation process. This means smaller investors could receive fewer shares than requested, or miss out entirely.

But here is the question I find more interesting:

If everyone wants a piece of Anthropic, does that make buying at the IPO price a better opportunity than waiting for the stock market debut?

1. Six times oversubscribed sounds impressive, but what does it mean?

Oversubscription means investors have submitted orders worth considerably more than the shares available.

However, it does not mean the share price will increase sixfold.

It also does not guarantee that every investor will receive an allocation.

There are three important numbers I would watch:

• Final IPO price: Does Anthropic price at $70, $78 or above the initial range?

• Allocation: How many shares are actually distributed to investors, particularly retail participants?

• Investor demand: Does strong demand remain when the shares begin trading publicly?

The final pricing and allocation figures will provide a more meaningful picture than subscription headlines alone.

2. Why I would be careful about chasing the IPO

At the upper end of the proposed range, Anthropic’s fully diluted valuation could reach approximately $1.4 trillion.

That is an enormous valuation, even for a company operating in one of the fastest-growing technology sectors.

Claude has become a major competitor in generative AI, while Claude Code and enterprise adoption provide additional growth opportunities.

However, the company faces several challenges:

• Significant computing and infrastructure expenses.

• Competition from OpenAI, Google and other AI developers.

• The need to convert revenue growth into sustainable profitability.

• Dependence on continued investment in advanced computing capacity.

The AI opportunity is substantial, but investors should not confuse a promising business with an attractive share price.

3. Three possible listing scenarios

Scenario A: ANT prices at $78 and opens significantly higher.

This would suggest strong demand has continued through the pricing process.

However, buying at a large premium could leave new investors exposed to profit-taking.

I would avoid assuming that a strong opening guarantees further gains.

Scenario B: ANT prices at the top of the range but trades close to $78.

This could indicate that the market is comfortable with the proposed valuation but is not willing to pay a substantial premium.

For investors who missed the IPO allocation, this could provide time to evaluate the company’s financial performance rather than rushing into the first trade.

Scenario C: ANT falls below its IPO price.

This would be worth investigating rather than automatically treating it as a bargain.

A decline could reflect broader technology market weakness, concerns about valuation or investors taking profits.

If the underlying business remains strong, a lower entry price could eventually become attractive. But understanding the reason for the decline is essential.

4. The private placement deserves attention too

Another important part of this offering is the separate $26 billion private placement.

According to the prospectus, Nvidia, Google, Microsoft, AMD, Broadcom, Micron and TSMC Partners are among the participants.

These investments highlight the strategic importance of Anthropic within the AI ecosystem.

However, the $26 billion should not be confused with money raised through the public IPO.

It involves a separate class of non-voting shares and is conditional on the offering.

It also raises an interesting question: major technology companies are investing in AI developers while simultaneously supplying the infrastructure they need.

This demonstrates how interconnected the AI industry has become.

5. My approach: Watch the price, not just the excitement

If I were considering an investment in ANT, I would pay attention to the following:

1. Final pricing: A price above $78 could indicate stronger-than-expected demand, but it would also mean a higher entry valuation.

2. Opening premium: The difference between the IPO price and first trading price will show how much investors are willing to pay in the secondary market.

3. Trading volume: Strong volume combined with price stability would be more informative than a brief opening spike.

4. Financial performance: Revenue growth, operating margins, cash flow and infrastructure commitments will matter more than IPO excitement over the long term.

I would not feel pressured to buy on the first day.

Missing an IPO allocation is not necessarily missing an investment opportunity. Public trading provides another chance to assess the company, although the price may be higher or lower than the IPO price.

My conclusion

I am interested in Anthropic because it represents an important part of the AI industry’s next stage.

However, I would rather buy a good company at a sensible valuation than chase a highly anticipated listing simply because everyone is talking about it.

The reported six-times oversubscription demonstrates strong interest, but the real test begins once shares are publicly traded.

Can Anthropic justify its valuation through sustained growth and improving profitability?

That is the question I believe long-term investors should focus on.

An IPO allocation may be difficult to secure, but there is no prize for being the first person to buy a stock. Sometimes waiting for the market to settle is a perfectly reasonable strategy.

For discussion purposes only. Not financial advice.

# Anthropic IPO Countdown: How to Position for Listing?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet